Skip to main content
. Author manuscript; available in PMC: 2021 Jun 10.
Published in final edited form as: Clin Immunol. 2019 Mar 26;202:49–58. doi: 10.1016/j.clim.2019.03.008

Fig. 1.

Fig. 1.

Increased frequency of ILCs in peripheral blood of SLE patients. PBMCs from healthy controls and SLE patients were stained for flow cytometry. (A) Single CD45+ lymphocytes were selected for ILCs analysis. ILCs were defined as Lin−CD127+ cells. Type 1, 2 and 3 ILC are identified by the expression of CRTH2, CD117 and NKp44. Representative gating strategy of ILCs in a healthy control (B) and a SLE patient (C). Percentages of ILC/Total cells (PBMC) (D) and ILC/Lymphocytes (E) in SLE patients (N = 49) and healthy controls (N = 20).